Practical Considerations: DCB vs Repeat Stenting With DES

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Daiichi-Sankyo/Elil Lilly and Company; InnoN Pharmaceuticals; Daewoong Pharmaceuticals; Shockwave Medical; Novartis; Amgen
• Non Executive Director (Board Member) - EzCaretech